Allena Pharmaceuticals
IPOPublic · Newton, United States · $93.0M raised
- Headquarters
- Newton
- Employees
- 51–200
- Business Model
- B2B
- Website
- allenapharma.com
- Total Funding
- $93.0M
- Last Round
- $53.0M Series CDec 2015
- Rounds
- 3
- Type
- Public
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
About
Allena Pharmaceuticals is a biopharmaceutical company dedicated to developing first-in-class oral enzyme therapeutics for rare and severe metabolic and kidney disorders. It pioneers ways to leverage oral enzymes with a novel biologic platform to treat metabolic disorders and beyond. Its oral enzyme platform is designed to treat patients with severe and underserved metabolic disorders by breaking down harmful substances.
Summary
Allena Pharmaceuticals is a Biotech company based in Newton, United States. It has raised $93.0M in total across 3 rounds, most recently a $53.0M Series C round in Dec 2015. Investors include PFM Health Sciences, HBM Partners and Bessemer Venture Partners.
Funding History
Nov 2017
Sign up to see all 4 events
Funding: Series A through Series C. Amounts, valuations, and investors where available.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
Integrated biopharmaceutical solutions company
BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/allena-pharmaceuticals"><img src="https://indexed.vc/api/badge/company/allena-pharmaceuticals" alt="Allena Pharmaceuticals on Indexed.vc" width="260" height="76" /></a>